293 related articles for article (PubMed ID: 33833737)
21. 5α-Dihydrotestosterone is a potent androgen in the fathead minnow (Pimephales promelas).
Margiotta-Casaluci L; Sumpter JP
Gen Comp Endocrinol; 2011 May; 171(3):309-18. PubMed ID: 21354156
[TBL] [Abstract][Full Text] [Related]
22. 11β-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione.
Swart AC; Schloms L; Storbeck KH; Bloem LM; Toit Td; Quanson JL; Rainey WE; Swart P
J Steroid Biochem Mol Biol; 2013 Nov; 138():132-42. PubMed ID: 23685396
[TBL] [Abstract][Full Text] [Related]
23. The potent synthetic androgens, dimethandrolone (7α,11β-dimethyl-19-nortestosterone) and 11β-methyl-19-nortestosterone, do not require 5α-reduction to exert their maximal androgenic effects.
Attardi BJ; Hild SA; Koduri S; Pham T; Pessaint L; Engbring J; Till B; Gropp D; Semon A; Reel JR
J Steroid Biochem Mol Biol; 2010 Oct; 122(4):212-8. PubMed ID: 20599615
[TBL] [Abstract][Full Text] [Related]
24. Fish androgen receptor: cDNA cloning, steroid activation of transcription in transfected mammalian cells, and tissue mRNA levels.
Todo T; Ikeuchi T; Kobayashi T; Nagahama Y
Biochem Biophys Res Commun; 1999 Jan; 254(2):378-83. PubMed ID: 9918846
[TBL] [Abstract][Full Text] [Related]
25. Antiandrogenic mechanisms of pesticides in human LNCaP prostate and H295R adrenocortical carcinoma cells.
Robitaille CN; Rivest P; Sanderson JT
Toxicol Sci; 2015 Jan; 143(1):126-35. PubMed ID: 25324206
[TBL] [Abstract][Full Text] [Related]
26. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
[TBL] [Abstract][Full Text] [Related]
27. Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer.
Chang KH; Li R; Papari-Zareei M; Watumull L; Zhao YD; Auchus RJ; Sharifi N
Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13728-33. PubMed ID: 21795608
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetic analysis of AKR1C2-4 and HSD17B6 genes in subjects 46,XY with hypospadias.
Mares L; Vilchis F; Chávez B; Ramos L
J Pediatr Urol; 2020 Oct; 16(5):689.e1-689.e12. PubMed ID: 32732174
[TBL] [Abstract][Full Text] [Related]
29. Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency.
Sasaki G; Ishii T; Hori N; Amano N; Homma K; Sato S; Hasegawa T
Endocr J; 2019 Sep; 66(9):837-842. PubMed ID: 31178538
[TBL] [Abstract][Full Text] [Related]
30. Inefficient UGT-conjugation of adrenal 11β-hydroxyandrostenedione metabolites highlights C11-oxy C
du Toit T; Swart AC
Mol Cell Endocrinol; 2018 Feb; 461():265-276. PubMed ID: 28939401
[TBL] [Abstract][Full Text] [Related]
31. Reprint of "Current perspectives on the androgen 5 alpha-dihydrotestosterone (DHT) and 5 alpha-reductases in teleost fishes and amphibians".
Martyniuk CJ; Bissegger S; Langlois VS
Gen Comp Endocrinol; 2014 Jul; 203():10-20. PubMed ID: 24954687
[TBL] [Abstract][Full Text] [Related]
32. Novel mutations of the SRD5A2 and AR genes in Thai patients with 46, XY disorders of sex development.
Ittiwut C; Pratuangdejkul J; Supornsilchai V; Muensri S; Hiranras Y; Sahakitrungruang T; Watcharasindhu S; Suphapeetiporn K; Shotelersuk V
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):19-26. PubMed ID: 27849622
[TBL] [Abstract][Full Text] [Related]
33. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.
Ito K; Suzuki T; Akahira J; Moriya T; Kaneko C; Utsunomiya H; Yaegashi N; Okamura K; Sasano H
Int J Cancer; 2002 Jun; 99(5):652-7. PubMed ID: 12115497
[TBL] [Abstract][Full Text] [Related]
34. Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells.
Zhu YS; Cai LQ; You X; Cordero JJ; Huang Y; Imperato-McGinley J
J Androl; 2003; 24(5):681-7. PubMed ID: 12954658
[TBL] [Abstract][Full Text] [Related]
35. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of androgen synthesis via 5alpha-reduced precursors.
Ghayee HK; Auchus RJ
Endocr Dev; 2008; 13():55-66. PubMed ID: 18493133
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis.
Mostaghel EA; Morgan A; Zhang X; Marck BT; Xia J; Hunter-Merrill R; Gulati R; Plymate S; Vessella RL; Corey E; Higano CS; Matsumoto AM; Montgomery RB; Nelson PS
PLoS One; 2014; 9(10):e111545. PubMed ID: 25356728
[TBL] [Abstract][Full Text] [Related]
38. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
39. Possible testosterone redundancy for 5α-dihydrotestosterone in the masculinization of mouse external genitalia.
Ueda Y; Suzuki K; Kajimoto M; Fujimoto K; Mahendroo M; Ema M; Yamada G; Hara I
Exp Anim; 2022 Nov; 71(4):451-459. PubMed ID: 35613877
[TBL] [Abstract][Full Text] [Related]
40. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
